These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 18515791)

  • 81. CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess.
    Chu PY; Zatta A; Kiriazis H; Chin-Dusting J; Du XJ; Marshall T; Kaye DM
    Circ Heart Fail; 2011 Sep; 4(5):651-8. PubMed ID: 21685249
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Hydrochlorothiazide Reduces Cardiac Hypertrophy, Fibrosis and Rho-Kinase Activation in DOCA-Salt Induced Hypertension.
    Mondaca-Ruff D; Araos P; Yañez CE; Novoa UF; Mora IG; Ocaranza MP; Jalil JE
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):724-735. PubMed ID: 34623176
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evolution of liver antioxidant status and iron implication during the development of deoxycorticosterone-saline hypertension in rats.
    Elhaïmeur F; Nicod L; Courderot-Masuyer C; Robin S; Guyon C; Bouhaddi M; Regnard J; Richert L; Berthelot A
    Biol Trace Elem Res; 2005 Dec; 107(3):263-76. PubMed ID: 16286682
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The role of the glucocorticoid receptor in mineralocorticoid/salt-mediated cardiac fibrosis.
    Rickard AJ; Funder JW; Fuller PJ; Young MJ
    Endocrinology; 2006 Dec; 147(12):5901-6. PubMed ID: 16990342
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension.
    Banek CT; Knuepfer MM; Foss JD; Fiege JK; Asirvatham-Jeyaraj N; Van Helden D; Shimizu Y; Osborn JW
    Hypertension; 2016 Dec; 68(6):1415-1423. PubMed ID: 27698066
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.
    Leelahavanichkul A; Yan Q; Hu X; Eisner C; Huang Y; Chen R; Mizel D; Zhou H; Wright EC; Kopp JB; Schnermann J; Yuen PS; Star RA
    Kidney Int; 2010 Dec; 78(11):1136-53. PubMed ID: 20736988
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Mineralocorticoid action and sodium-hydrogen exchange: studies in experimental cardiac fibrosis.
    Young M; Funder J
    Endocrinology; 2003 Sep; 144(9):3848-51. PubMed ID: 12933657
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Does the Sabra hypertension-prone rat represent a model of salt or mineralocorticoid sensitivity?
    Yagil Y; Yagil C
    J Hypertens; 1998 Oct; 16(10):1481-4. PubMed ID: 9814619
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat.
    Griffin KA; Picken MM; Bidani AK
    Kidney Int; 2004 Jan; 65(1):209-18. PubMed ID: 14675052
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effect of vitamin E therapy on serum uric acid in DOCA-salt-treated rats.
    Seifi B; Kadkhodaee M; Zahmatkesh M
    Acta Physiol Hung; 2011 Jun; 98(2):214-20. PubMed ID: 21616780
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats.
    Machnik A; Dahlmann A; Kopp C; Goss J; Wagner H; van Rooijen N; Eckardt KU; Müller DN; Park JK; Luft FC; Kerjaschki D; Titze J
    Hypertension; 2010 Mar; 55(3):755-61. PubMed ID: 20142563
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Mineralocorticoid pretreatment enhances angiotensin II-induced neuronal excitation but not salt drinking in male Fischer rats.
    Omouessi ST; Falconetti C; Chapleur M; Fernette B; Thornton SN
    J Neuroendocrinol; 2007 Feb; 19(2):109-15. PubMed ID: 17214873
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats.
    Jadhav A; Torlakovic E; Ndisang JF
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F521-34. PubMed ID: 19116243
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Hydralazine reduces leukocyte migration through different mechanisms in spontaneously hypertensive and normotensive rats.
    Rodrigues SF; de Oliveira MA; dos Santos RA; Soares AG; de Cássia Tostes R; Carvalho MH; Fortes ZB
    Eur J Pharmacol; 2008 Jul; 589(1-3):206-14. PubMed ID: 18554582
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Antihypertensive action of indapamide. Comparative studies in several experimental models.
    Kyncl J; Oheim K; Seki T; Solles A
    Arzneimittelforschung; 1975 Oct; 25(10):1491-5. PubMed ID: 1243026
    [TBL] [Abstract][Full Text] [Related]  

  • 96. 19-Hydroxyandrostenedione amplifies the hypertensive action of mineralocorticoids in rats.
    Sekihara H; Yazaki Y; Kojima T
    J Endocrinol; 1993 Jul; 138(1):31-40. PubMed ID: 7852890
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Multiple Sclerosis Drug Fingolimod Induces Thrombotic Microangiopathy in Deoxycorticosterone Acetate/Salt Hypertension.
    Iwazu Y; Muto S; Ioka T; Watanabe Y; Iwazu K; Kusano E; Nagata D
    Hypertension; 2018 Sep; 72(3):776-784. PubMed ID: 30354753
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Thiazide diuretics, endothelial function, and vascular oxidative stress.
    Zhou MS; Schulman IH; Jaimes EA; Raij L
    J Hypertens; 2008 Mar; 26(3):494-500. PubMed ID: 18300860
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Endothelin-1 contributes to the sexual differences in renal damage in DOCA-salt rats.
    Montezano AC; Callera GE; Mota AL; Fortes ZB; Nigro D; Carvalho MH; Zorn TM; Tostes RC
    Peptides; 2005 Aug; 26(8):1454-62. PubMed ID: 16042985
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats.
    Kagitani S; Ueno H; Hirade S; Takahashi T; Takata M; Inoue H
    J Hypertens; 2004 May; 22(5):1007-15. PubMed ID: 15097242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.